SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 305 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $209,915 | -35.2% | 1,523 | -39.1% | 0.07% | -39.1% |
| Q4 2022 | $323,950 | +17.4% | 2,500 | 0.0% | 0.11% | -21.4% |
| Q3 2022 | $276,000 | +0.4% | 2,500 | -32.0% | 0.14% | +13.8% |
| Q2 2022 | $275,000 | -15.1% | 3,675 | -11.4% | 0.12% | +9.8% |
| Q1 2022 | $324,000 | -13.4% | 4,150 | 0.0% | 0.11% | +9.8% |
| Q4 2021 | $374,000 | -2.6% | 4,150 | 0.0% | 0.10% | -8.1% |
| Q3 2021 | $384,000 | +64.8% | 4,150 | +32.8% | 0.11% | +40.5% |
| Q1 2021 | $233,000 | – | 3,125 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |